Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy

NCT00232596 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

306

Enrollment

INDUSTRY

Sponsor class

Conditions

Seizures

Interventions

DRUG: Retigabine
DRUG: Placebo

Sponsor

GlaxoSmithKline

Collaborators

[object Object]